Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,809
Closed -$1.65M 3484
2026
Q1
$1.65M Buy
21,809
+4,857
+29% +$365K ﹤0.01% 1587
2025
Q4
$1.26M Sell
16,952
-28,595
-63% -$2.09M ﹤0.01% 1590
2025
Q3
$3.07M Buy
45,547
+7,288
+19% +$484K 0.01% 1094
2025
Q2
$2.49M Sell
38,259
-13,428
-26% -$805K ﹤0.01% 1113
2025
Q1
$3.19M Sell
51,687
-4,877
-9% -$323K 0.01% 915
2024
Q4
$4.58M Sell
56,564
-3,320
-6% -$259K 0.01% 751
2024
Q3
$4.88M Buy
59,884
+20,132
+51% +$1.61M 0.01% 701
2024
Q2
$2.95M Sell
39,752
-30,432
-43% -$2.28M 0.01% 765
2024
Q1
$5.47M Buy
70,184
+64,727
+1,186% +$4.82M 0.01% 628
2023
Q4
$390K Buy
+5,457
New +$380K ﹤0.01% 1385
2023
Q3
Sell
-5,449
Closed -$441K 1531
2023
Q2
$441K Buy
5,449
+283
+5% +$23.1K ﹤0.01% 1235
2023
Q1
$417K Buy
5,166
+759
+17% +$61.1K ﹤0.01% 1386
2022
Q4
$330K Buy
+4,407
New +$314K ﹤0.01% 1111
2022
Q3
Sell
-3,145
Closed -$218K 1207
2022
Q2
$218K Buy
3,145
+32
+1% +$2.38K ﹤0.01% 1047
2022
Q1
$240K Buy
3,113
+24
+0.8% +$1.73K ﹤0.01% 806
2021
Q4
$236K Buy
3,089
+222
+8% +$16.3K ﹤0.01% 871
2021
Q3
$212K Buy
+2,867
New +$215K ﹤0.01% 639
2021
Q2
Sell
-4,290
Closed -$319K 720
2021
Q1
$319K Buy
4,290
+508
+13% +$38.6K 0.01% 540
2020
Q4
$275K Buy
3,782
+97
+3% +$6.85K 0.01% 541
2020
Q3
$245K Buy
+3,685
New +$233K 0.01% 433
2018
Q2
Sell
-10,133
Closed -$379K 555
2018
Q1
$379K Sell
10,133
-6
-0.1% -$242 0.03% 384
2017
Q4
$433K Sell
10,139
-3
-0% -$120 0.03% 362
2017
Q3
$372K Sell
10,142
-15,832
-61% -$639K 0.03% 385
2017
Q2
$2.1M Buy
25,974
+15,891
+158% +$701K 0.18% 109
2017
Q1
$429K Buy
+10,083
New +$411K 0.04% 275

Other funds holding HOLX

Cerity Partners's HOLX Position: Q2 2026 in Review

Cerity Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 21,809 shares — an estimated $1.65M sold.

Cerity Partners first reported a position in HOLX in Q1 2017 and held it in 25 quarters. The position peaked at $5.47M in Q1 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Cerity Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Cerity Partners sold 21,809 Hologic shares in Q2 2026, an estimated $1.65M.
  • Cerity Partners first reported a position in Hologic in Q1 2017 and held it in 25 quarters.
  • Cerity Partners's Hologic position peaked at $5.47M in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.